{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:42:37Z","timestamp":1787010157868,"version":"build-2736575974"},"reference-count":41,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"45","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"State Key Scientific and Technological Research Programs","award":["2017ZX10203207-003-0020"],"award-info":[{"award-number":["2017ZX10203207-003-0020"]}]},{"name":"Science and Technological Supports Project of Sichuan Province","award":["2019YJ0149"],"award-info":[{"award-number":["2019YJ0149"]}]},{"name":"Science and Technological Supports Project of Sichuan Province","award":["2018SZ0204"],"award-info":[{"award-number":["2018SZ0204"]}]},{"name":"Health and Family Planning Commission of Sichuan Province","award":["17PJ393"],"award-info":[{"award-number":["17PJ393"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>There is little information concerning the predictive ability of the preoperative platelet to albumin ratio (PAR) in hepatocellular carcinoma (HCC) patients after liver resection. In the current study, we aimed to assess the prognostic power of the PAR in HCC patients without portal hypertension (PH) following liver resection.<\/jats:p>\n                    <jats:p>Approximately 628 patients were included in this study. A receiver operating characteristic (ROC) curve analysis was performed to evaluate the predictive value of the PAR for both recurrence-free survival (RFS) and overall survival (OS). Univariate and multivariate analyses were used to identify the independent risk factors for both RFS and OS.<\/jats:p>\n                    <jats:p>During the follow-up period, 361 patients experienced recurrence, and 217 patients died. ROC curve analysis suggested that the best cut-off value of the PAR for RFS was greater than 4.8. The multivariate analysis revealed that microvascular invasion (MVI), tumor size &gt;5\u200acm, high aspartate aminotransferase-to-platelet count ratio index (APRI) and high PAR were four independent risk factors for both RFS and OS. Patients with a low PAR had significantly better RFS and OS than those with a high PAR.<\/jats:p>\n                    <jats:p>The PAR may be a useful marker to predict the prognosis of HCC patients after liver resection. HCC patients with a high preoperative PAR had a higher recurrent risk and lower long-term survival rate than those with a low preoperative PAR.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000017920","type":"journal-article","created":{"date-parts":[[2019,11,7]],"date-time":"2019-11-07T20:40:07Z","timestamp":1573159207000},"page":"e17920","source":"Crossref","is-referenced-by-count":21,"title":["The preoperative platelet to albumin ratio predicts the prognosis of hepatocellular carcinoma patients without portal hypertension after liver resection"],"prefix":"10.1097","volume":"98","author":[{"given":"Chuan","family":"Li","sequence":"first","affiliation":[{"name":"Department of Liver Surgery"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Peng","sequence":"additional","affiliation":[{"name":"Department of Liver Surgery"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Yun","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Liver Surgery"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian-Fu","family":"Wen","sequence":"additional","affiliation":[{"name":"Department of Liver Surgery"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Ping","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Biliary Surgery, West China Hospital of Sichuan University, Chengdu, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2019,11]]},"reference":[{"key":"R1-20230915","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3322\/caac.21262","article-title":"Global cancer statistics, 2012","volume":"65","author":"Torre","year":"2015","journal-title":"CA Cancer J Clin"},{"key":"R2-20230915","doi-asserted-by":"crossref","first-page":"353","DOI":"10.21037\/hbsn.2018.08.01","article-title":"Multidisciplinary management of recurrent and metastatic hepatocellular carcinoma after resection: an international expert consensus","volume":"7","author":"Wen","year":"2018","journal-title":"Hepatobiliary Surg Nutr"},{"key":"R3-20230915","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S1535-6108(04)00058-3","article-title":"Focus on hepatocellular carcinoma","volume":"5","author":"Bruix","year":"2004","journal-title":"Cancer Cell"},{"key":"R4-20230915","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.critrevonc.2006.06.001","article-title":"Treatment of hepatocellular carcinoma","volume":"60","author":"Forner","year":"2006","journal-title":"Crit Rev Oncol Hematol"},{"key":"R5-20230915","doi-asserted-by":"crossref","first-page":"16611","DOI":"10.1038\/s41598-018-34543-z","article-title":"Pretreatment inflammation-based markers predict survival outcomes in patients with early stage hepatocellular carcinoma after radiofrequency ablation","volume":"8","author":"Chu","year":"2018","journal-title":"Sci Rep"},{"key":"R6-20230915","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1002\/jso.24197","article-title":"Significance of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio and prognostic nutrition index as preoperative predictors of early mortality after liver resection for huge (\u2265\u200a10\u200acm) hepatocellular carcinoma","volume":"113","author":"Goh","year":"2016","journal-title":"J Surg Oncol"},{"key":"R7-20230915","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1111\/hepr.12835","article-title":"Preoperative platelet-to-lymphocyte ratio can predict recurrence beyond the Milan criteria after hepatectomy for patients with hepatocellular carcinoma","volume":"47","author":"Kaida","year":"2017","journal-title":"Hepatol Res"},{"key":"R8-20230915","doi-asserted-by":"crossref","first-page":"5607","DOI":"10.3748\/wjg.v21.i18.5607","article-title":"Significance of platelet count and platelet-based models for hepatocellular carcinoma recurrence","volume":"21","author":"Pang","year":"2015","journal-title":"World J Gastroenterol"},{"key":"R9-20230915","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/0016-5085(95)90450-6","article-title":"Risk factors for intrahepatic recurrence in human small hepatocellular carcinoma","volume":"108","author":"Adachi","year":"1995","journal-title":"Gastroenterology"},{"key":"R10-20230915","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.jss.2015.06.012","article-title":"Postoperative complications are predictive of poor prognosis in hepatocellular carcinoma","volume":"199","author":"Harimoto","year":"2015","journal-title":"J Surg Res"},{"key":"R11-20230915","doi-asserted-by":"crossref","first-page":"754","DOI":"10.3892\/ol.2015.3304","article-title":"Low local blood perfusion, high white blood cell and high platelet count are associated with primary tumor growth and lung metastasis in a 4T1 mouse breast cancer metastasis model","volume":"10","author":"Wang","year":"2015","journal-title":"Oncol Lett"},{"key":"R12-20230915","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.7150\/thno.17908","article-title":"Inhibition of platelet function using liposomal nanoparticles blocks tumor metastasis","volume":"7","author":"Zhang","year":"2017","journal-title":"Theranostics"},{"key":"R13-20230915","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1159\/000488420","article-title":"Neutrophil-to-lymphocyte ratio and platelet count predict long-term outcome of stage IIIC epithelial ovarian cancer","volume":"46","author":"Zhou","year":"2018","journal-title":"Cell Physiol Biochem"},{"key":"R14-20230915","doi-asserted-by":"crossref","first-page":"827","DOI":"10.2217\/fon-2018-0591","article-title":"The pretreatment platelet count is an independent predictor of tumor progression in patients undergoing transcatheter arterial chemoembolization with hepatitis B virus-related hepatocellular carcinoma","volume":"15","author":"Wang","year":"2019","journal-title":"Future Oncol"},{"key":"R15-20230915","first-page":"3","article-title":"Platelet count as a predictor of metastasis and venous thromboembolism in patients with cancer","author":"Sylman","year":"2017","journal-title":"Converg Sci Phys Oncol"},{"key":"R16-20230915","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ijsu.2015.03.006","article-title":"Preoperative platelet count and volume could not help predict PONV in women undergoing breast cancer surgery: a prospective cohort study","volume":"18","author":"Obrink","year":"2015","journal-title":"Int J Surg"},{"key":"R17-20230915","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1007\/s11605-017-3632-6","article-title":"Predictors of futile liver resection for patients with Barcelona clinic liver cancer stage B\/C hepatocellular carcinoma","volume":"22","author":"Li","year":"2018","journal-title":"J Gastrointest Surg"},{"key":"R18-20230915","doi-asserted-by":"crossref","first-page":"787","DOI":"10.21873\/anticanres.11378","article-title":"Preoperative platelet-to-albumin ratio predicts prognosis of patients with pancreatic ductal adenocarcinoma after pancreatic resection","volume":"37","author":"Shirai","year":"2017","journal-title":"Anticancer Res"},{"key":"R19-20230915","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jss.2015.05.003","article-title":"Postoperative neutrophil-to-lymphocyte ratio plus platelet-to-lymphocyte ratio predicts the outcomes of hepatocellular carcinoma","volume":"198","author":"Li","year":"2015","journal-title":"J Surg Res"},{"key":"R20-20230915","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1002\/jhbp.114","article-title":"Comparison of inflammation-based prognostic scores as predictors of tumor recurrence in patients with hepatocellular carcinoma after curative resection","volume":"21","author":"Yamamura","year":"2014","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"R21-20230915","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1111\/jvh.12010","article-title":"Comparison of FIB-4 and APRI in Chinese HBV-infected patients with persistently normal ALT and mildly elevated ALT","volume":"20","author":"Wang","year":"2013","journal-title":"J Viral Hepat"},{"key":"R22-20230915","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1111\/liv.12199","article-title":"Influence of clinically significant portal hypertension on survival after hepatic resection for hepatocellular carcinoma in cirrhotic patients","volume":"33","author":"Giannini","year":"2013","journal-title":"Liver Int"},{"key":"R23-20230915","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1002\/ijc.27441","article-title":"Tumor-platelet interaction in solid tumors","volume":"130","author":"Buergy","year":"2012","journal-title":"Int J Cancer"},{"key":"R24-20230915","first-page":"987","article-title":"Preoperative platelet to albumin ratio predicts outcome of patients with cholangiocarcinoma","volume":"38","author":"Saito","year":"2018","journal-title":"Anticancer Res"},{"key":"R25-20230915","doi-asserted-by":"crossref","first-page":"42","DOI":"10.4251\/wjgo.v9.i1.42","article-title":"Pre-treatment platelet counts as a prognostic and predictive factor in stage II and III rectal adenocarcinoma","volume":"9","author":"Steele","year":"2017","journal-title":"World J Gastrointest Oncol"},{"key":"R26-20230915","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1056\/NEJMoa1110352","article-title":"Paraneoplastic thrombocytosis in ovarian cancer","volume":"366","author":"Stone","year":"2012","journal-title":"N Engl J Med"},{"key":"R27-20230915","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/nrc3004","article-title":"Contribution of platelets to tumour metastasis","volume":"11","author":"Gay","year":"2011","journal-title":"Nat Rev Cancer"},{"issue":"(Suppl 2)","key":"R28-20230915","doi-asserted-by":"crossref","first-page":"S149","DOI":"10.1016\/S0049-3848(14)50025-4","article-title":"Mechanistic explanation for platelet contribution to cancer metastasis","volume":"133","author":"Stegner","year":"2014","journal-title":"Thromb Res"},{"key":"R29-20230915","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1182\/blood-2004-06-2272","article-title":"Platelets and fibrin(ogen) increase metastatic potential by impeding natural killer cell-mediated elimination of tumor cells","volume":"105","author":"Palumbo","year":"2005","journal-title":"Blood"},{"key":"R30-20230915","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1158\/0008-5472.CAN-11-1872","article-title":"Platelet-derived MHC class I confers a pseudonormal phenotype to cancer cells that subverts the antitumor reactivity of natural killer immune cells","volume":"72","author":"Placke","year":"2012","journal-title":"Cancer Res"},{"key":"R31-20230915","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1111\/hepr.12651","article-title":"High platelet counts increase metastatic risk in huge hepatocellular carcinoma undergoing transarterial chemoembolization","volume":"46","author":"Xue","year":"2016","journal-title":"Hepatol Res"},{"key":"R32-20230915","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/j.1478-3231.2010.02436.x","article-title":"Predictive factors for long-term survival in patients with clinically significant portal hypertension following resection of hepatocellular carcinoma","volume":"31","author":"Choi","year":"2011","journal-title":"Liver Int"},{"key":"R33-20230915","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1002\/bjs.8951","article-title":"Severity of portal hypertension and prediction of postoperative liver failure after liver resection in patients with Child-Pugh grade A cirrhosis","volume":"99","author":"Chen","year":"2012","journal-title":"Br J Surg"},{"key":"R34-20230915","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1007\/s00330-016-4604-z","article-title":"The impact of clinically significant portal hypertension on the prognosis of patients with hepatocellular carcinoma after radiofrequency ablation: a propensity score matching analysis","volume":"27","author":"Fang","year":"2017","journal-title":"Eur Radiol"},{"key":"R35-20230915","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.hpb.2018.07.005","article-title":"Impact of clinically significant portal hypertension on outcomes after partial hepatectomy for hepatocellular carcinoma: a systematic review and meta-analysis","volume":"21","author":"Liu","year":"2019","journal-title":"HPB (Oxford)"},{"key":"R36-20230915","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1007\/s00268-017-4355-2","article-title":"Postoperative albumin-bilirubin grade change predicts the prognosis of patients with hepatitis B-related hepatocellular carcinoma within the Milan criteria","volume":"42","author":"Li","year":"2018","journal-title":"World J Surg"},{"key":"R37-20230915","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1200\/JCO.2014.57.9151","article-title":"Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade","volume":"33","author":"Johnson","year":"2015","journal-title":"J Clin Oncol"},{"key":"R38-20230915","doi-asserted-by":"crossref","first-page":"4138","DOI":"10.1245\/s10434-015-4516-1","article-title":"Prognostic nutritional index (PNI) predicts tumor recurrence of very early\/early stage hepatocellular carcinoma after surgical resection","volume":"22","author":"Chan","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"R39-20230915","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1159\/000488215","article-title":"Preoperative controlling nutritional status score predicts mortality after hepatectomy for hepatocellular carcinoma","volume":"36","author":"Takagi","year":"2019","journal-title":"Dig Surg"},{"key":"R40-20230915","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1159\/000471807","article-title":"Role of albumin in growth inhibition in hepatocellular carcinoma","volume":"93","author":"Bagirsakci","year":"2017","journal-title":"Oncology"},{"key":"R41-20230915","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1475-2891-9-69","article-title":"Pretreatment serum albumin as a predictor of cancer survival: a systematic review of the epidemiological literature","volume":"9","author":"Gupta","year":"2010","journal-title":"Nutr J"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000017920","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T17:46:28Z","timestamp":1694799988000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000017920"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":41,"journal-issue":{"issue":"45","published-online":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000017920","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11]]}}}